Oculis announces publication of Phase 2 data showing topical

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease Positive Phase 2 data, published

Related Keywords

China , Paris , France General , France , Switzerland , Brigid Lee , Amber Fennell , Ericb Papas , Louie Anne Gauthier , Sylvia Cheung , Matthew Cole , Esther Chan , Kostenloser Wertpapierhandel , Christophe Baudouin , National Ophthalmology Hospital , Eudeseuropean Dry Eye Society , Consilium Strategic Communications , Clinical Ophthalmology , Quinze Vingts National Ophthalmology Hospital , Dry Eye Disease , Oculis Ophthalmology Franchise , Riad Sherif , Anne Gauthier , Strategic Marketing , Cindy Lung , Eye Disease , Dry Eye Society , Eye Disease Landscape , Dry Eye So Difficult , Oculis , Nnounces , Publication , Hase , Data , Showing , Ropical , Crops , Anti , Unfa , Agent , Icaminlimab , Relieves , Persistent , Secular , Discomfort , Evere , Disease ,